Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05REH
|
||||
| Former ID |
DIB011182
|
||||
| Drug Name |
Flosulide
|
||||
| Synonyms |
CGP-28238; CGP-28328; CGS-28238; SH-459; ZK-38997
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Terminated | [544771] | ||
| Company |
Novartis AG
|
||||
| Formula |
C16H13F2NO4S
|
||||
| Canonical SMILES |
S(=O)(=O)(Nc1c(cc2c(c1)CCC2=O)Oc1c(cc(cc1)F)F)C
|
||||
| CAS Number |
CAS 80937-31-1
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin G/H synthase 2 | Target Info | Modulator | [525636] | |
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| NF-kappa B signaling pathway | |||||
| VEGF signaling pathway | |||||
| TNF signaling pathway | |||||
| Retrograde endocannabinoid signaling | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Oxytocin signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Leishmaniasis | |||||
| Pathways in cancer | |||||
| Chemical carcinogenesis | |||||
| MicroRNAs in cancer | |||||
| Small cell lung cancer | |||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.